Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
D-CYPHR is a South Africa-based proteomics and metabolomics service organization and molecular phenotyping core facility serving research and commercial projects. The organization provides discovery and targeted proteomics, metabolomics, protein biomarker analysis, and array-based immunoproteomics services, supporting customers from experimental design through data generation and analysis. Its platform includes mass spectrometry workflows, Olink protein panels, and Sengenics array-based assays, with applications spanning health research, biomarker discovery, agriculture, and environmental science. D-CYPHR appears to operate as an active service platform rather than a therapeutic drug developer, so it does not have a conventional clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on D-CYPHR.